By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 104
NEW YORK (Reuters Health) – Patients with osteogenesis imperfecta face an increased risk of cardiovascular abnormalities, researchers from Norway report in the March American Heart Journal. Osteogenesis imperfecta…
NEW YORK (Reuters Health) – There is some evidence to support the use of immunosuppressive therapy to avoid relapse in inflammatory bowel disease (IBD), but more research is…
NEW YORK (Reuters Health) – Drugs currently available for patients with heart failure with preserved ejection fraction (HFpEF) have no mortality benefit, according to a meta-analysis published in…
NEW YORK (Reuters Health) – When patients with chronic obstructive pulmonary disease (COPD) come down with community-acquired pneumonia, whether or not they use inhaled corticosteroids has no effect…
NEW YORK (Reuters Health) – Eye drops containing lubricants, corticosteroids, cyclosporine, or autologous serum improve dry eye symptoms associated with Sjögren’s syndrome (SS), according to a literature review.…
NEW YORK (Reuters Health) – Bosentan is not an effective therapy for patients with idiopathic pulmonary fibrosis (IPF), suggests a new study organized by the company that makes…
NEW YORK (Reuters Health) – Adding extra protein to enteral nutrition for critically ill children is safe and may help improve their protein metabolism, Spanish researchers report. Critically…
NEW YORK (Reuters Health) – There is no conclusive evidence that anti-arryhthmic drugs extend overall survival after cardiac arrest, the authors of a new research review conclude. These…
NEW YORK (Reuters Health) – The presence of low-frequency HIV-1 drug resistance mutations – especially against non-nucleoside reverse transcriptase inhibitors (NNRTIs) – confers a greater than twofold increased…
NEW YORK (Reuters Health) – In women with metastatic breast cancer, a longer duration of chemotherapy is associated with a clinically meaningful and statistically significant improvement in time…
